TechTaffy

tech:

taffy

BenevolentAI raises $115 million

By TechTaffy Desk

London-based BenevolentAI, an AI company with pharmaceutical discovery and clinical development capabilities, has raised $115 million at a pre-money valuation of $2 billion, in one of the largest funding rounds in the AI pharmaceutical sector.

The majority of investors are from the United States.  The balance of raised funds came from existing investors, including Woodford Investment Management, said the company in a statement. Credit Suisse acted as the placement agent for the company. Additional details of the financing was not disclosed.

BenevolentAI has raised more than $200 million in funding since its inception in 2013. The company was founded by Ken Mulvany.

Read a blog post by Mr. Mulvany on the funding here.

[Image courtesy: BenevolentAI]

Just in

Fundings

AlphaSense raises $650M

AlphaSense, a market intelligence and search platform, has raised $650 million in funding, co-led by Viking Global Investors and BDT & MSD Partners.
Around the web

Elon Musk’s xAI raises $6B to take on OpenAI — VentureBeat

Confirming reports from April, the series B investment comes from the participation of multiple known venture capital firms and investors, including Valor Equity Partners, Vy Capital, Andreessen Horowitz (A16z), Sequoia Capital, Fidelity Management & Research Company, Prince Alwaleed Bin Talal and Kingdom Holding, writes Shubham Sharma. 
IT

Capgemini partners with DARPA to explore quantum computing for carbon capture

Capgemini Government Solutions has launched a new initiative with the Defense Advanced Research Projects Agency (DARPA) to investigate quantum computing's potential in carbon capture.
IT

Harness acquires Split Software

Harness has entered into an agreement to acquire Split Software, a provider of feature management and experimentation solutions.
AI

Snowflake to acquire TruEra AI observability platform

Snowflake has entered into a definitive agreement to acquire TruEra, providers of an AI observability platform. Financial terms of the transaction were not disclosed.